2018-09-28 | variant's name changed from c.[1210-34TG[13];1210-12T[5]] to c.1210-34_1210-6TG[13]T[5] |
2024-10-14 | Class updated from varying clinical consequence to disease-causing - varying clinical consequence (low penetrance of CF) |
2024-12-09 | Variant classified as varying clinical consequence (low penetrance of CF) on the basis of epidemiological data (in particular high frequency in the general population), the number and type of diagnosis for patients reported in CFTR-France and functional data |
Variant NM_000492.4:c.1210-34_1210-6TG[13]T[5]
Name | NM_000492.4:c.1210-34_1210-6TG[13]T[5] |
#Exon/intron | intron 9 |
Legacy Name | TG13T5 |
Class | disease-causing |
Subclass | varying clinical consequence |
complex allele in 7.41% of patients associated with |
![]() Not found |
![]() | dbSNP no rs |
![]() Not found | ![]() Not found |
No patient found in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 108 |
---|---|
Asymptomatic compound heterozygote | 5 |
CF | 7 |
CFTR-RD | 91
|
Pending | 1 |
Pending (NBS) | 4 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CBAVD | 4971 | heterozygote | CF-causing - Cis CF-causing - Trans |
CBAVD | 2040 | heterozygote | VUS3- Undef |
CBAVD | 2060 | heterozygote | CF-causing - Trans |
CBAVD | 2114 | heterozygote | CF-causing - Trans |
CBAVD | 2232 | heterozygote | CF-causing - Trans |
CBAVD | 2582 | heterozygote | CFTR-RD-causing- Undef VUS3- Undef |
CBAVD | 4932 | heterozygote | CF-causing - Trans |
CBAVD | 4944 | heterozygote | CF-causing- Undef |
CBAVD | 2683 | heterozygote | CF-causing - Trans |
CBAVD | 6398 | heterozygote | CF-causing- Undef |
CBAVD | 1801 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 5049 | heterozygote | VUS3- Undef |
CBAVD | 1908 | heterozygote | CF-causing - Trans |
CBAVD | 5393 | heterozygote | CF-causing- Undef |
CBAVD | 5704 | heterozygote | CF-causing- Undef |
CBAVD | 6392 | heterozygote | CF-causing- Undef |
CBAVD | 2816 | heterozygote | CF-causing - Trans |
CBAVD | 4622 | heterozygote | CF-causing - Trans |
CBAVD | 5591 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 5325 | heterozygote | CF-causing - Trans |
CBAVD | 5765 | heterozygote | CF-causing- Undef |
CBAVD | 5766 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 6320 | heterozygote | CF-causing- Undef |
CBAVD | 4599 | heterozygote | CFTR-RD-causing - Cis CFTR-RD-causing - Trans |
CBAVD | 6322 | heterozygote | likely CFTR-RD- Undef |
CBAVD | 6463 | heterozygote | CF-causing- Undef |
CBAVD | 3369 | heterozygote | CF-causing - Trans |
CBAVD | 3334 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 4663 | heterozygote | CF-causing- Undef |
CBAVD | 4755 | heterozygote | CF-causing - Trans |
CBAVD | 2976 | heterozygote | CF-causing - Trans |
CBAVD | 3280 | heterozygote | CF-causing- Undef |
CBAVD | 3291 | heterozygote | CF-causing - Trans |
CBAVD | 3293 | heterozygote | CF-causing - Trans |
CBAVD | 3295 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 3332 | heterozygote | varying clinical consequence - Trans |
CBAVD | 6472 | heterozygote | CF-causing- Undef VUS3- Undef |
CBAVD | 4707 | heterozygote | CF-causing- Undef |
CBAVD | 786 | heterozygote | CF-causing - Trans |
CBAVD | 837 | heterozygote | CF-causing - Trans |
CBAVD | 894 | heterozygote | VUS3 - Trans |
CBAVD | 4828 | heterozygote | CF-causing- Undef |
CBAVD | 5521 | heterozygote | varying clinical consequence- Undef |
CBAVD | 656 | heterozygote | CF-causing- Undef |
CBAVD | 81 | heterozygote | CF-causing - Trans |
CBAVD | 4956 | heterozygote | VUS3- Undef |
CBAVD | 397 | heterozygote | CF-causing - Trans |
CBAVD | 426 | heterozygote | CF-causing - Trans |
CBAVD | 470 | heterozygote | CF-causing - Trans |
CBAVD | 474 | heterozygote | CF-causing - Trans |
CBAVD | 493 | heterozygote | CF-causing - Trans |
CBAVD | 653 | heterozygote | CFTR-RD-causing - Trans varying clinical consequence- Undef |
CBAVD | 1426 | heterozygote | CF-causing - Trans |
CBAVD | 1427 | heterozygote | CF-causing - Trans |
CBAVD | 1431 | heterozygote | CF-causing- Undef |
CBAVD | 1441 | heterozygote | CF-causing - Trans |
CBAVD | 1443 | heterozygote | CF-causing - Trans |
CBAVD | 1445 | heterozygote | VUS3- Undef |
CBAVD | 1450 | heterozygote | CF-causing - Trans |
CBAVD | 1482 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1504 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1505 | heterozygote | CF-causing - Trans |
CBAVD | 1506 | heterozygote | CF-causing - Trans |
CBAVD | 1417 | heterozygote | CF-causing - Trans |
CBAVD | 1410 | heterozygote | CF-causing- Undef |
CBAVD | 1404 | heterozygote | CF-causing - Trans |
CBAVD | 859 | heterozygote | CF-causing - Trans |
CBAVD | 1267 | heterozygote | CF-causing - Trans |
CBAVD | 1318 | heterozygote | CF-causing - Trans |
CBAVD | 1264 | heterozygote | CF-causing - Trans |
CBAVD | 1333 | heterozygote | CF-causing - Trans |
CBAVD | 1352 | heterozygote | |
CBAVD | 1274 | heterozygote | CF-causing - Trans |
CBAVD | 6468 | homozygote | c.1210-34_1210-6TG[13]T[5] - Trans |
CBAVD | 2238 | homozygote | c.1210-34_1210-6TG[13]T[5] - Trans |
CBAVD | 1281 | homozygote | c.1210-34_1210-6TG[13]T[5] - Trans |
CBAVD | 6249 | homozygote | c.1210-34_1210-6TG[13]T[5] - Trans |
CBAVD | 3357 | homozygote | c.1210-34_1210-6TG[13]T[5] - Trans |
CF | 2597 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 2672 | heterozygote | CFTR-RD-causing - Trans |
CF | 5373 | heterozygote | CF-causing- Undef |
CF | 4732 | heterozygote | CF-causing - Trans |
CF | 570 | heterozygote | CF-causing - Trans |
CF | 1317 | heterozygote | CF-causing - Trans |
CF | 4871 | heterozygote | CF-causing - Trans |
Other | 2544 | heterozygote | CF-causing - Trans |
Other | 5671 | heterozygote | CF-causing - Trans |
Other | 5677 | heterozygote | CF-causing - Trans |
Other | 5701 | heterozygote | varying clinical consequence- Undef |
Other | 6355 | heterozygote | CF-causing - Trans |
Other | 5128 | heterozygote | CF-causing - Trans |
Other | 87 | heterozygote | CF-causing - Trans |
Other | 1089 | heterozygote | |
Pending (NBS) | 6397 | heterozygote | CF-causing- Undef |
Pending (NBS) | 6333 | heterozygote | CFTR-RD-causing - Trans |
Pending (NBS) | 646 | heterozygote | CF-causing - Trans |
Pending (NBS) | 1255 | heterozygote | CF-causing - Trans |
Pancreatitis | 5339 | heterozygote | CFTR-RD-causing- Undef |
Pancreatitis | 5949 | heterozygote | CF-causing - Trans |
Pancreatitis | 776 | heterozygote | CF-causing - Trans |
Asymptomatic compound heterozygote | 6440 | heterozygote | CF-causing - Trans |
Asymptomatic compound heterozygote | 3020 | heterozygote | CF-causing - Trans |
Asymptomatic compound heterozygote | 3031 | heterozygote | CF-causing - Trans |
Asymptomatic compound heterozygote | 3333 | heterozygote | varying clinical consequence - Trans |
Asymptomatic compound heterozygote | 817 | heterozygote | CFTR-RD-causing - Trans |
Bronchiectasis | 6350 | heterozygote | CF-causing- Undef |
Pending | 1097 | heterozygote | VUS3 - Trans |
CRS-NP | 6279 | heterozygote | CF-causing - Trans |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|